Page 5 - Publish Ahead News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Publish ahead. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Publish Ahead Today - Breaking & Trending Today

'We Are Polite': When a Retraction Notice Pulls Punches

'We Are Polite': When a Retraction Notice Pulls Punches
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

Charles Marc Samama , Anhui Medical University , Anhui Medical , European Journal , Marc Samama , Publish Ahead , அன்ஹுய் மருத்துவ பல்கலைக்கழகம் , அன்ஹுய் மருத்துவ , ஐரோப்பிய இதழ் ,

Vitamin D deficiency may lead to more pain following total knee replacement

Vitamin D deficiency may lead to more pain following total knee replacement
According to the study, published in
Menopause, the journal of
The North American Menopause Society (NAMS), vitamin D plays a role in the degree of postoperative pain postmenopausal women experience after undergoing total knee replacement.
During perimenopause, the ovaries make less estrogen. This could result in estrogen deficiency, which along with inactivity and a lack of sun exposure, have been linked to vitamin D deficiency in this age group.
“Estrogen deficiency in perimenopausal women is associated with decreased levels of vitamin D. In addition, low dietary intake of vitamin D, impaired skin synthesis of vitamin D, a sedentary lifestyle that reduces sunlight exposures and decreased hydroxylation of the liver and kidneys also contribute to vitamin D deficiency in perimenopausal women,” the authors noted. ....

United States , Stephanie Faubion , American Menopause Society , North American Menopause Society , Publish Ahead , ஒன்றுபட்டது மாநிலங்களில் , மாற்றாந்தாய் போஉபிொன் , அமெரிக்கன் மாதவிடாய் சமூகம் , வடக்கு அமெரிக்கன் மாதவிடாய் சமூகம் ,

Novaliq Announces More than 50% Patients Enrolled in CyclASol® Phase 3 Dry Eye Disease Trial ESSENCE-2

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

United States , Baden Wüberg , United Kingdom , Christian Roesky , Novaliq Gmb , Prnewswire Novaliq , Clinical Development At Novaliq , International Journal Of Pharmaceutics , Gmbh Co , Drug Administration , Novaliq Inc , New Drug Application , Vice President Clinical Development , Hopp Biotech , Dry Eye Disease , Randomized Phase , Publish Ahead , Clinical Phase , Assess Efficacy , Waterfree Cyclosporine Formulation , Dry Eye , Pr Newswire , Corona Virus , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , கஂப் இணை ,

Bausch + Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction

/PRNewswire/ Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company"), and. ....

Baden Wuberg , United Kingdom , United States , Lainie Keller , Novaliq Gmb , Simone Angstmann Mehr , Arthur Shannon , Bausch Health Companies Inc , Bausch Health Investor Contact , Exchange Commission , Gmbh Co , Bausch Health Media Contact , Bausch Lomb Incorporated , Health Sciences , Bausch Health , Novaliq Inc , Hall Primary , Secondary Endpoints Were Achieved , Bausch Health Companies , Novaliq Gmbh , Corneal Fluorescein , Corneal Fluorescein Staining , Hopp Biotech , Health Companies , Canadian Securities Administrators , Dry Eye ,

Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03

Bausch + Lomb Completes Enrollment Of First Phase 3 Study For NOV03
Phase 2 Study Published in Cornea: The Journal of Cornea and External Disease ; Study Met Primary Endpoint in Patients with Highly Symptomatic Evaporative Dry Eye Disease Associated with Meibomian Gland Dysfunction Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. and Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced …
Phase 2 Study Published in
Cornea: The Journal of Cornea and External Disease ; Study Met Primary Endpoint in Patients with Highly Symptomatic Evaporative Dry Eye Disease Associated with
Meibomian Gland Dysfunction
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSETSX: BHC) (“Bausch Health” or the “Company”), and Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced the ....

United States , Baden Wuberg , United Kingdom , Christian Roesky , Lainie Keller , Novaliq Gmb , Joseph Tauber , Josephc Papa , Simone Angstmann Mehr , Arthur Shannon , Bausch Health Companies Inc , Bausch Health Investor Contact , Exchange Commission , Gmbh Co , Tauber Eye Center , Bausch Health Media Contact , Bausch Lomb Incorporated , Health Sciences , Bausch Health , Novaliq Inc , External Disease , Study Met Primary Endpoint , Meibomian Gland Dysfunction , Bausch Health Companies , Novaliq Gmbh , Kansas City ,